Emergent Biosolutions Inc. sell JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€1.86
Target price
20.11.24
-
Performance (%)
360.76%
End price
21.11.24
€8.58
Summary
This prediction ended on 21.11.24 with a price of €8.58. The price for Emergent Biosolutions Inc. massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Emergent Biosolutions Inc. | -6.714% | -6.714% | -4.440% |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Ratings data for EBS provided by MarketBeat
In the thread Trading Emergent Biosolutions Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten